BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23200108)

  • 1. Bone complications of mastocytosis: a link between clinical and biological characteristics.
    Guillaume N; Desoutter J; Chandesris O; Merlusca L; Henry I; Georgin-Lavialle S; Barete S; Hirsch I; Bouredji D; Royer B; Gruson B; Lok C; Sevestre H; Mentaverri R; Brazier M; Meynier J; Hermine O; Marolleau JP; Kamel S; Damaj G
    Am J Med; 2013 Jan; 126(1):75.e1-7. PubMed ID: 23200108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis.
    Rossini M; Zanotti R; Bonadonna P; Artuso A; Caruso B; Schena D; Vecchiato D; Bonifacio M; Viapiana O; Gatti D; Senna G; Riccio A; Passalacqua G; Pizzolo G; Adami S
    Bone; 2011 Oct; 49(4):880-5. PubMed ID: 21782049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
    Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
    J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress markers are increased in patients with mastocytosis.
    Gangemi S; Minciullo PL; Magliacane D; Saitta S; Loffredo S; Saija A; Cristani M; Marone G; Triggiani M
    Allergy; 2015 Apr; 70(4):436-42. PubMed ID: 25630934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease spectrum in patients with elevated serum tryptase levels.
    Aberer E; Savic S; Bretterklieber A; Reiter H; Berghold A; Aberer W
    Australas J Dermatol; 2015 Feb; 56(1):7-13. PubMed ID: 24575854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary 11β-PGF2α and N-methyl histamine correlate with bone marrow biopsy findings in mast cell disorders.
    Divekar R; Butterfield J
    Allergy; 2015 Oct; 70(10):1230-8. PubMed ID: 26095439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An increased bone mineral density is an adverse prognostic factor in patients with systemic mastocytosis.
    Riffel P; Schwaab J; Lutz C; Naumann N; Metzgeroth G; Fabarius A; Schoenberg SO; Hofmann WK; Valent P; Reiter A; Jawhar M
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):945-951. PubMed ID: 31980928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone and Cytokine Markers Associated With Bone Disease in Systemic Mastocytosis.
    Rama TA; Henriques AF; Matito A; Jara-Acevedo M; Caldas C; Mayado A; Muñoz-González JI; Moreira A; Cavaleiro-Rufo J; García-Montero A; Órfão A; Sanchez-Muñoz L; Álvarez-Twose I
    J Allergy Clin Immunol Pract; 2023 May; 11(5):1536-1547. PubMed ID: 36801493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
    Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous manifestations in Hymenoptera and Diptera anaphylaxis: relationship with basal serum tryptase.
    Potier A; Lavigne C; Chappard D; Verret JL; Chevailler A; Nicolie B; Drouet M
    Clin Exp Allergy; 2009 May; 39(5):717-25. PubMed ID: 19302252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels.
    Zanotti R; Lombardo C; Passalacqua G; Caimmi C; Bonifacio M; De Matteis G; Perbellini O; Rossini M; Schena D; Busa M; Marcotulli MC; Bilò MB; Franchini M; Marchi G; Simioni L; Bonadonna P
    J Allergy Clin Immunol; 2015 Jul; 136(1):135-9. PubMed ID: 25605272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum tryptase and SCORMA (SCORing MAstocytosis) Index as disease severity parameters in childhood and adult cutaneous mastocytosis.
    Heide R; van Doorn K; Mulder PG; van Toorenenbergen AW; Beishuizen A; de Groot H; Tank B; Oranje AP
    Clin Exp Dermatol; 2009 Jun; 34(4):462-8. PubMed ID: 19077102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa.
    Grinspoon S; Baum H; Lee K; Anderson E; Herzog D; Klibanski A
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3864-70. PubMed ID: 8923830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow tryptase as a possible diagnostic criterion for adult systemic mastocytosis.
    Bulai Livideanu C; Apoil PA; Lepage B; Eischen M; Laurent C; Laharrague P; Lamant L; Tournier E; Tavitian S; Pouplard C; Recher C; Laroche M; Mailhol C; Dubreuil P; Hermine O; Blancher A; Paul C
    Clin Exp Allergy; 2016 Jan; 46(1):133-41. PubMed ID: 26767494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients.
    Theoharides TC; Boucher W; Spear K
    Int Arch Allergy Immunol; 2002 Aug; 128(4):344-50. PubMed ID: 12218373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cell activation syndrome: improved identification by combined determinations of serum tryptase and 24-hour urine 11β-prostaglandin2α.
    Ravi A; Butterfield J; Weiler CR
    J Allergy Clin Immunol Pract; 2014; 2(6):775-8. PubMed ID: 25439370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM.
    Alvarez-Twose I; Zanotti R; González-de-Olano D; Bonadonna P; Vega A; Matito A; Sánchez-Muñoz L; Morgado JM; Perbellini O; García-Montero A; De Matteis G; Teodósio C; Rossini M; Jara-Acevedo M; Schena D; Mayado A; Zamò A; Mollejo M; Sánchez-López P; Cabañes N; Orfao A; Escribano L; ;
    J Allergy Clin Immunol; 2014 Feb; 133(2):520-8. PubMed ID: 23921094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of tryptase in anaphylaxis and mastocytosis.
    Schwartz LB
    Immunol Allergy Clin North Am; 2006 Aug; 26(3):451-63. PubMed ID: 16931288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure.
    Rix M; Andreassen H; Eskildsen P; Langdahl B; Olgaard K
    Kidney Int; 1999 Sep; 56(3):1084-93. PubMed ID: 10469378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum tryptase correlates with the KIT D816V mutation burden in adults with indolent systemic mastocytosis.
    Kristensen T; Broesby-Olsen S; Vestergaard H; Bindslev-Jensen C; Møller MB;
    Eur J Haematol; 2013 Aug; 91(2):106-11. PubMed ID: 23621866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.